The FDA’s framework for AI regulation, while robust for premarket evaluation, would benefit from more specific mechanisms for continuous monitoring of AI performance in diverse real-world settings.

On behalf of the Board of Directors, management, and employees of Outlook Therapeutics, I want to extend my deepest gratitude ...

When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...

With little fanfare, the Biden administration stacked a critical committee that helps set U.S. vaccination policy with new ...

The Trump administration dismissed members of the Environmental Protection Agency’s (EPA) Clean Air Scientific Advisory Committee and Science Advisory Board on Tuesday, a day before the ...

Kennedy Jr., Trump's pick for HHS secretary. However, it remains unclear how much could actually change if Kennedy were to be ...

News-Medical speaks with Jordi Labs’ about its recent achievements, alignment with FDA expectations, and strategic ...

W ith respiratory-disease season in full swing and a bird flu outbreak rapidly evolving, the new Trump Administration has ...

The City of DuBois-Sandy Township joint consolidation board, at Wednesday’s meeting, agreed to adopt the revised organizational chart as Exhibit B of the consolidation agreement, with the understandin ...

Development of such drug-delivering microrobots is at the forefront of biomedical engineering research. However, there are many challenges to overcome before this minimally invasive technology moves ...

Companies say they are working to update their products to comply with the Food and Drug Administration's decision Wednesday to ban the artificial food dye Red 3, after the agency said it was ...

Food and Drug Administration officials granted a 2022 petition filed ... The group points to research by scientific committees operated by the United Nations and the World Health Organization, ...